Doxorubicin-loaded platelets conjugated with anti-CD22 mAbs: a novel targeted delivery system for lymphoma treatment with cardiopulmonary avoidance

B-cell lymphoma accounts for approximately 85% of all adult non-Hodgkin's lymphoma cases. Doxorubicin (DOX) is an indispensable drug for the treatment of non-Hodgkin's lymphoma. However, DOX causes severe cardiotoxicity, which limits its use in conventional treatment strategies. In this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Peipei, Zuo, Huaqin, Zhou, Rongfu, Wang, Fan, Liu, Xu, Ouyang, Jian, Chen, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601655/
https://www.ncbi.nlm.nih.gov/pubmed/28938559
http://dx.doi.org/10.18632/oncotarget.16871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601655/
https://www.ncbi.nlm.nih.gov/pubmed/28938559
http://dx.doi.org/10.18632/oncotarget.16871

Ejemplares similares